N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
N-truncated Aβ4-42 is highly abundant in Alzheimer disease (AD) brain and was the first Aβ peptide discovered in AD plaques. However, a possible role in AD aetiology has largely been neglected. In the present report, we demonstrate that Aβ4-42 rapidly forms aggregates possessing a high aggregation propensity in terms of monomer consumption and oligomer formation. Short-term treatment of primary cortical neurons indicated that Aβ4-42 is as toxic as pyroglutamate Aβ3-42 and Aβ1-42. In line with these findings, treatment of wildtype mice using intraventricular Aβ injection induced significant working memory deficits with Aβ4-42, pyroglutamate Aβ3-42 and Aβ1-42. Transgenic mice expressing Aβ4-42 (Tg4-42 transgenic line) developed a massive CA1 pyramidal neuron loss in the hippocampus. The hippocampus-specific expression of Aβ4-42 correlates well with age-dependent spatial reference memory deficits assessed by the Morris water maze test. Our findings indicate that N-truncated Aβ4-42 triggers acute and long-lasting behavioral deficits comparable to AD typical memory dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As Aβ4–42 is predominantly expressed in the CA1 region in Tg4–42hom mice [21], hippocampal mRNA extracts were used for the analysis of both transgenes.”
From Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Tg4–42 mouse model used in the present study primarily shows an intraneuronal accumulation of Aβ peptides, in particular in CA1 hippocampal neurons, and does not form overt extracellular plaques [21].”
From Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Spatial reference memory in 5xFAD Lrp1 BE -/-mice and 5xFAD Lrp1 BE fl/fl control mice was assessed using the Morris water maze (40) by a blinded investigator as described previously (41).”
From Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier (2015) · cites this paper as [41]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We have recently generated a transgenic mouse model (Tg4–42) that overexpresses Aβ4–42 peptides under the control of the murine neuron-specific Thy1-promoter [21].”
From Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau (2021) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“In brief, the human Aβ4-42 sequence is fused to the signal peptide sequence of the thyrotropin-releasing hormone and the expression is under the control of the Thy1 promoter.”
From Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedPfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180 · cited 1×
“Spatial reference memory in Tg4-42 mice was evaluated using the Morris water maze [39].”
MethodAlzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 2×
“1 3 There is increasing evidence that the primary insult in AD is caused by oligomeric species derived from fulllength Aβ1-42 impairing synaptic functions [14, 67].”
BackgroundMorris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629 · cited 1×
“The order in which these entry points were used varied between training days [65].”
BackgroundAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · cited 2×
“In vitro and in vivo analysis of amyloid deposits in AD revealed N- and C-terminal variants of the Aβ peptide [33, 35, 48].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 6×
“In 5XFAD, another mouse model expressing mutant APP and PS1 [42], a heterogeneous mixture of full-length, N-truncated and modified Aβ peptides, including Aβ4-42, were found [70].”
BackgroundInfluentialDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“Small, soluble Aβ1-42 oligomers ranging in size from dimers to dodecamers have been found as key drivers of neurotoxicity in vitro and in vivo [6, 28, 30, 43, 61, 71].”
Background
Cited by
Items 101–176 of 176
Jin, H., Chen, T., Li, G., Wang, C., Zhang, B., Cao, X., Sha, S., Wan, Q., & Chen, L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150782 · Cited by 17
Gerberding, A.-L., Zampar, S., Stazi, M., Liebetanz, D., & Wirths, O. (2019) · ASN NEURO · doi:10.1177/1759091419892692 · Cited by 19
Self-citationMeißner, J. N., Bouter, Y., & Bayer, T. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142868 · Cited by 16
Self-citationKarkisaval, A. G., Hassan, R., Nguyen, A., Balster, B., Abedin, F., Lal, R., & Tatulian, S. A. (2024) · Nature Communications · doi:10.1038/s41467-023-43821-y · Cited by 19
Zhang, W. I., Antonios, G., Rábano, A., Bayer, T. A., Schneider, A., & Rizzoli, S. O. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150064 · Cited by 17
Self-citationN-Terminal Truncated Aβ4-42 Is a Substrate for Neprilysin Degradation in vitro and in vivo
Hornung, K. A., Zampar, S., Engel, N., Klafki, H., Liepold, T., Bayer, T. A., Wiltfang, J., Jahn, O., & Wirths, O. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181134 · Cited by 16
Self-citationHinteregger, B., Loeffler, T., Flunkert, S., Neddens, J., Bayer, T. A., Madl, T., & Hutter‐Paier, B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201204 · Cited by 16
Self-citationDeshpande, P., Chen, C., Chimata, A. V., Li, J., Sarkar, A., Yeates, C. J., Chen, C., Kango‐Singh, M., & Singh, A. (2024) · Cell Death and Disease · doi:10.1038/s41419-023-06361-3 · Cited by 17
Kuhn, A. J., Chan, K., Sajimon, M., Yoo, S., Serrão, V. H. B., Lee, J., Abrams, B. S., Nowick, J. S., Uversky, V. N., Wheeler, C. J., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c11511 · Cited by 16
Schrempel, S., Kottwitz, A. K., Piechotta, A., Gnoth, K., Büschgens, L., Hartlage‐Rübsamen, M., Morawski, M., Schenk, M., Kleinschmidt, M., Serrano, G. E., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02824-9 · Cited by 18
Self-citationN‑terminal Domain of Amyloid‑β Impacts Fibrillation and Neurotoxicity
Shi, J., Li, H., Liu, H., Zhu, L., Guo, Y.-B., Pei, J., An, H., Li, Y., Li, S.-D., Zhang, Z., et al. (2022) · ACS Omega · doi:10.1021/acsomega.2c04583 · Cited by 14
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 16
Hu, Z., Cruceta, L., Zhang, S., Sun, Y. P., & Qiang, W. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00341 · Cited by 15
Cai, C., Wang, L., Li, S., Lou, S.-C., Luo, J., Fu, D., & Chen, T. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1989-21.2022 · Cited by 14
Coordination of Redox Ions within a Membrane-Binding Peptide: A Tale of Aromatic Rings
Fu, R., Rooney, M. T., Zhang, R., & Cotten, M. L. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c00636 · Cited by 13
Dunkelmann, T., Schemmert, S., Honold, D., Teichmann, K., Butzküven, E., Demuth, H., Shah, N. J., Langen, K., Kutzsche, J., Willbold, D., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170775 · Cited by 15
Seeding and Cross-Seeding Aggregations of Aβ40 and Its N-Terminal-Truncated Peptide Aβ11–40
Hao, X., Zheng, J., Sun, Y. P., & Dong, X. (2019) · Langmuir · doi:10.1021/acs.langmuir.8b03599 · Cited by 14
Stazi, M., & Wirths, O. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112951 · Cited by 14
Self-citationSompol, P. M., Gollihue, J. L., Kraner, S. D., Artiushin, I. A., Cloyd, R., Chishti, E. A., Koren, S. A., Nation, G. K., Abisambra, J. F., Huzián, O., et al. (2021) · Aging Cell · doi:10.1111/acel.13416 · Cited by 13
Amyloid-β deposits in human astrocytes contain truncated and highly resistant proteoforms
Beretta, C., Svensson, E., Dakhel, A., Zyśk, M., Hanrieder, J., Sehlin, D., Michno, W., & Erlandsson, A. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103916 · Cited by 14
Watremez, W., Jackson, J. D., Almari, B., McLean, S. L., Grayson, B., Neill, J. C., Fischer, N., Allouche, A., Koziel, V., Pillot, T., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170489 · Cited by 14
Self-citationMatrix Development for the Detection of Phosphorylated Amyloid-β Peptides by MALDI-TOF-MS
Liepold, T., Klafki, H., Kumar, S., Walter, J., Wirths, O., Wiltfang, J., & Jahn, O. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00270 · Cited by 13
Self-citationBRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells
Campo, M. D., Oliveira, C. R., Scheper, W., Zwart, R., Korth, C., Müller‐Schiffmann, A., Kostallas, G., Biverstål, H., Presto, J., Johansson, J., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1769-y · Cited by 12
N-Terminally Truncated Aß Peptide Variants in Alzheimer’s Disease
Wirths, O., Zampar, S., & Weggen, S. (2019) · Codon Publications eBooks · doi:10.15586/alzheimersdisease.2019.ch7 · Cited by 19
Self-citationVemulapalli, S. P. B., Becker, S., Griesinger, C., & Rezaei‐Ghaleh, N. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c02595 · Cited by 12
Self-citationDistinct Aggregation Behavior of N-Terminally Truncated Aβ4–42 Over Aβ1–42 in the Presence of Zn(II)
Na, C., Kim, M., Kim, G., Lin, Y., Lee, Y., Bal, W., Nam, E., & Lim, M. H. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00831 · Cited by 11
Stazi, M., Zampar, S., Klafki, H., Meyer, T., & Wirths, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032155 · Cited by 11
Self-citationBouter, Y., Meller, B., Sahlmann, C. O., Wolf, B., Langer, L., Bankstahl, J. P., Wester, H. J., Kropf, S., Meller, J., & Bouter, C. (2018) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0971-18-04 · Cited by 11
Self-citationWang, Y., Shi, Z., Zhang, Y., Yan, J., Yu, W., & Chen, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595360 · Cited by 12
Bouter, Y., Kacprowski, T., Rößler, F., Jensen, L. R., Kuss, A. W., & Bayer, T. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580524 · Cited by 11
Self-citationMadhavadas, S., Subramanian, S., & Kutty, B. (2017) · Physiology International · doi:10.1556/2060.104.2017.4.7 · Cited by 11
Oxidase Reactivity of CuII Bound to N-Truncated Aβ Peptides Promoted by Dopamine
Bacchella, C., Dell’Acqua, S., Nicolis, S., Monzani, E., & Casella, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105190 · Cited by 10
Stazi, M., Zampar, S., Nadolny, M., Büschgens, L., Meyer, T., & Wirths, O. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01431-7 · Cited by 9
Self-citationTransgene integration causes RARB downregulation in homozygous Tg4–42 mice
Hinteregger, B., Loeffler, T., Flunkert, S., Neddens, J., Birner‐Gruenberger, R., Bayer, T. A., Madl, T., & Hutter‐Paier, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-63512-8 · Cited by 9
Self-citationMutual structural effects of unmodified and pyroglutamylated amyloid β peptides during aggregation
Abedin, F., & Tatulian, S. A. (2021) · Journal of Peptide Science · doi:10.1002/psc.3312 · Cited by 10
Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia
Souchet, B., Audrain, M., Alves, S., Fol, R. R., Tada, S., Orefice, N. S., Potier, B., Dutar, P., Billard, J., Cartier, N., et al. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.67 · Cited by 10
Haessler, A., Gier, S., Jung, N., & Windbergs, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1516093 · Cited by 10
Deleanu, M., Hernandez, J., Cottet, H., & Chamieh, J. (2022) · Electrophoresis · doi:10.1002/elps.202200192 · Cited by 9
Solid-phase synthesis and pathological evaluation of pyroglutamate amyloid-β3-42 peptide
Cho, I., Lee, H., Lee, D.-H., Park, I. W., Yoon, S., Kim, H. Y., & Kim, Y. S. (2023) · Scientific Reports · doi:10.1038/s41598-022-26616-x · Cited by 7
Guan, Y., Li, Y., Gao, W., Mei, J., Xu, W. W., Wang, C., & Ai, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00585 · Cited by 7
Bacchella, C., Caro, S. D., Nicolis, S., Monzani, E., & Dell’Acqua, S. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112775 · Cited by 7
Lio, C. T., Kacprowski, T., Klaedtke, M., Jensen, L. R., Bouter, Y., Bayer, T. A., & Kuss, A. W. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220110 · Cited by 8
Self-citationRichard, B. C., Bayer, T. A., Lind, S. B., Shevchenko, G., & Bergquist, J. (2019) · Clinical mass spectrometry · doi:10.1016/j.clinms.2019.07.001 · Cited by 6
Self-citationMital, M., Szutkowski, K., Bossak‐Ahmad, K., Skrobecki, P., Drew, S. C., Poznański, J. T., Zhukov, I., Frączyk, T., & Bal, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239200 · Cited by 6
Modulation of the Activity of the Insulin-Degrading Enzyme by Aβ Peptides
Kemeh, M. M., & Lazo, N. D. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00384 · Cited by 6
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 8
Self-citationImmunotherapy Against N-Truncated Amyloid-β Oligomers
Bayer, T. A., & Wirths, O. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_3 · Cited by 4
Self-citationA Question of Origins: Non-neuronal Sources of Amyloid-β
Sasmita, A. O., & Depp, C. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-025-01572-4 · Cited by 5
Büschgens, L., Hempel, N., Methi, A., Fischer, A., Siering, N., Piepkorn, L., Jahn, O., Meyer, T., & Wirths, O. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02313-w · Cited by 3
Self-citationSchleicher, E. M., Bayer, T. A., Iseni, T., Ott, F. W., Wagner, J. M., Viotti, J., Dresbach, T., & Bouter, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911159 · Cited by 4
Self-citationDuan, S., Li, C., Gao, Y., Meng, P., Ji, S., Xu, Y., Mao, Y., Wang, H., & Tian, J. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03226-0 · Cited by 2
Ott, F. W., Sichler, M. E., Bouter, C., Enayati, M., Wiltfang, J., Bayer, T. A., Beindorff, N., Löw, M. J., & Bouter, Y. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241306770 · Cited by 2
Self-citationModulation of Aβ 1–40 and Aβ 4–40 co-assembly by zinc: getting closer to the biological reality
de Cremoux, L., Falcone, E., Schmitt, D. A., Stefaniak, E., Wiśniewska, M., Vitale, N., Bal, W., & Hureau, C. (2025) · Inorganic Chemistry Frontiers · doi:10.1039/d5qi00850f · Cited by 3
Ponnusankar, S., Som, S., Antony, J., & Dhanabal, S. P. (2021) · Pharmacognosy Magazine · doi:10.4103/pm.pm_518_20 · Cited by 2
Marsh, S. (2015) · Research Explorer (The University of Manchester) · Cited by 2
Viotti, J., Ott, F. W., Schleicher, E. M., Wagner, J. M., Bouter, Y., Bayer, T. A., & Dresbach, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/560896 · Cited by 2
Self-citationAllouche, A., Colin, J., Birck, C., Schroeder, H., Tallandier, V., Baldoni, M., Muller, C., Afrassi, M., & Violle, N. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02051-2 · Cited by 1
Pereira, T. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.502 · Cited by 1
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Antonios, G. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5611 · Cited by 1
Adhikari, R. (2019) · Digital Commons - Michigan Tech (Michigan Technological University) · doi:10.37099/mtu.dc.etdr/891 · Cited by 1
Biophysical Analysis of the Structure and Aggregation of Amyloid beta Peptide
Abedin, F. (2021) · STARS (University of Central Florida)
Zampar, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9004
Caffeine and potential use in Alzheimer’s disease
Büschgens, L., Janitschke, D., Lauer, A. A., Grimm, M. O. W., & Wirths, O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13868-3.00029-6
Self-citationRuoff, L. K., Bänfer, I. W. H., Liedtke, D. E., China, S. E., Wiltfang, J., Bayer, T. A., Bock, S., Spandau, F., Bouter, C., Beindorff, N., et al. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174127
Self-citationExpression und Prozessierung von APP cis-Dimeren in Abhängigkeit von LRP1
Herr, U.-M. (2017) · Gutenberg Open Science · doi:10.25358/openscience-1353
Identification of a novel Aβ(pGlu3-x) targeting pathway in Alzheimer’s diseasePreprint
Roßner, S., Schrempel, S., Höfling, C., Minister, C., Liepold, T., Naumann, M., Kottwitz, A. K., Schau, M., Fricke, M., Hartlage‐Rübsamen, M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8850276/v1
Self-citationdel Valle, M. L., & Arienzo, D. (2026) · Ibrain · doi:10.1002/ibra.70016
Valverde, A. (2020) · theses.fr (ABES) · doi:10.70675/f1b70734zf4e3z4870z8fbdz950d831642a7
Zampar, S., Fricke, M., Kremser, F., Talucci, I., Maric, H. M., Klafki, H., Rostagno, A. A., Jahn, O., Weggen, S., Ghiso, J. A., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05912-x
Self-citationTrigger-day hCG effects on DNA methylation and neurodevelopment in ART offspring
Jiang, Y., Wei, X., Liu, X., Zhou, J., Han, M., Zhao, A., Lv, H., Jiang, Y., Gu, Y., Wang, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74712-7
Sequential Molecular Interactions Shape Aβ42 Aggregation, Propagation, and ToxicityPreprint
Curto, J. S., Collell, G. P., Ruiz, M., Villegas, S., Fernández, M. R., & de Groot, N. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.27.747468
Abd-Elraouf, K., Murphy, D. T., Cheong, L. Y. T., Zeng, J., & Lo, C. H. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00591-z · Cited by 1
Bacchella, C., Bertinelli, A., Ferraresi, A., Nicolis, S., Monzani, E., & Dell’Acqua, S. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218752
Metadata
- Authors
- Bouter, Y., Dietrich, K., Wittnam, J. L., Rezaei-Ghaleh, N., Pillot, T., Papot-Couturier, S., Lefebvre, T., Sprenger, F., Wirths, O., Zweckstetter, M., & Bayer, T. A.
- Affiliations
- Universitätsmedizin Göttingen (DE)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Bayer, Thomas A.
- Venue
- Acta Neuropathologica
- Published
- 2013-05-18
- Volume
- 126
- Issue
- 2
- Pages
- 189-205
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3722453
- OpenAlex
- W2142807222
- Cited by
- 175
- References
- 71
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 8 · 2023: 11 · 2022: 16 · 2021: 22 · 2020: 16 · 2019: 16 · 2018: 14 · 2017: 12 · 2016: 13 · 2015: 17 · 2014: 12 · 2013: 2
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- DZNE Pub (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid fibril formation, amyloid-beta 42, neurotoxicity, working memory deficits, spatial reference memory, transgenic mice, amyloid plaques, behavioral deficits
- MeSH terms
- Alzheimer Disease, Amyloid, Animals, Behavior, Animal, Female, Fetus, Humans, Injections, Intraventricular, Male, Mice, Inbred C57BL, Mice, Transgenic, Molecular Weight, Nerve Degeneration, Neurons, Pregnancy, Solubility, Space Perception, Amyloid beta-Peptides, Rats, Wistar, Maze Learning, Microscopy, Electron, Transmission, Mice, Rats, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.